Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) ...

In another case study, CyPath® Lung helped physicians identify and treat a recurrence of breast cancer in a high-risk patient.

Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India's first AI-led ...

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026LONDON and PHOENIX, Ariz., March 18, 2025 ...

It invested in a robotic, noninvasive technology for biopsies of hard-to-reach lesions in the lungs and to remove suspected ...

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

Continental Hospitals in Hyderabad integrates AI for early cancer detection, saving lives and reducing treatment costs in ...

Dr. John deGraft-Johnson, a thoracic surgeon, used the Ion Robot for a biopsy of the lung nodule Nov. 19, which came back positive for cancer. The tumor was removed two days before Christmas.

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Good Samaritan announced in a recent press release the addition of the Ion Endoluminal System, a state-of-the-art ...

ALTON - OSF St. Anthony’s Moeller Cancer Center will host low-dose CT clinics to identify and diagnose lung cancer.Dana Matesa, RN, and Brandy Baxley, ...